Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$834M |
| 2 |
FedEx
FDX
|
+$666M |
| 3 |
Microsoft
MSFT
|
+$594M |
| 4 |
Advanced Micro Devices
AMD
|
+$585M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$403M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$2.17B |
| 2 |
Amazon
AMZN
|
+$1.98B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.79B |
| 4 |
NVIDIA
NVDA
|
+$1.18B |
| 5 |
Wells Fargo
WFC
|
+$827M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.89% |
| 2 | Consumer Discretionary | 1.29% |
| 3 | Communication Services | 0.93% |
| 4 | Healthcare | 0.89% |
| 5 | Financials | 0.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
PUT
Charter Communications
CHTR
$17.9B
| $519M | 0.07% |
713,100
+64,200
| +10% | +$48.7M |
|
227
PUT
Thermo Fisher Scientific
TMO
$233B
| $519M | 0.07% |
894,800
+361,800
| +68% | +$199M |
|
228
CALL
Oracle
ORCL
$422B
| $518M | 0.07% |
5,948,200
+821,500
| +16% | +$72.6M |
|
229
Mastercard
MA
$509B
| $518M | 0.07% |
1,490,259
+594,234
| +66% | +$216M |
|
230
CALL
iShares MSCI Brazil ETF
EWZ
$8.52B
| $518M | 0.07% |
16,113,700
+1,131,600
| +8% | +$41.4M |
|
231
CALL
Regeneron Pharmaceuticals
REGN
$85.9B
| $517M | 0.07% |
855,000
+97,200
| +13% | +$60.3M |
|
232
PUT
CVS Health
CVS
$119B
| $515M | 0.07% |
6,072,600
+251,700
| +4% | +$21.1M |
|
233
CALL
AbbVie
ABBV
$468B
| $514M | 0.07% |
4,766,700
-1,337,900
| -22% | -$153M |
|
234
PUT
American Airlines Group
AAL
$9.15B
| $512M | 0.07% |
24,962,800
+2,505,000
| +11% | +$50.8M |
|
235
Qualcomm
QCOM
$169B
| $507M | 0.07% |
3,927,901
+1,623,632
| +70% | +$230M |
|
236
CALL
United Parcel Service
UPS
$86.8B
| $505M | 0.07% |
2,772,300
+4,000
| +0.1% | +$790K |
|
237
CALL
Match Group
MTCH
$9.38B
| $504M | 0.07% |
3,211,700
+1,546,400
| +93% | +$235M |
|
238
PUT
AutoZone
AZO
$48.3B
| $502M | 0.07% |
295,900
+87,300
| +42% | +$140M |
|
239
Booking.com
BKNG
$158B
| $494M | 0.07% |
5,206,150
+1,774,425
| +52% | +$159M |
|
240
PUT
Beyond Meat
BYND
$254M
| $494M | 0.07% |
156,387
-23,210
| -13% | -$85.2M |
|
241
PUT
DraftKings
DKNG
$13B
| $491M | 0.07% |
10,191,500
+3,365,600
| +49% | +$178M |
|
242
PUT
iShares China Large-Cap ETF
FXI
$4.28B
| $490M | 0.07% |
12,577,200
+5,946,000
| +90% | +$246M |
|
243
PUT
MongoDB
MDB
$34.7B
| $489M | 0.07% |
1,038,000
+300
| +0% | +$121K |
|
244
PUT
Johnson & Johnson
JNJ
$651B
| $486M | 0.07% |
3,006,700
+430,600
| +17% | +$73.5M |
|
245
VanEck Gold Miners ETF
GDX
$31.8B
| $485M | 0.07% |
16,444,855
+2,268,626
| +16% | +$73.9M |
|
246
PUT
McDonald's
MCD
$192B
| $483M | 0.06% |
2,005,200
+633,000
| +46% | +$151M |
|
247
CALL
TSMC
TSM
$2.17T
| $481M | 0.06% |
4,306,200
+674,600
| +19% | +$79.2M |
|
248
CALL
Peloton Interactive
PTON
$2.37B
| $478M | 0.06% |
5,492,800
-79,400
| -1% | -$8.78M |
|
249
NIO
NIO
$11.6B
| $474M | 0.06% |
13,291,499
+5,416,425
| +69% | +$223M |
|
|
250
PUT
AbbVie
ABBV
$468B
| $473M | 0.06% |
4,380,300
-349,700
| -7% | -$40M |
|
Similar funds
Jeff Yass's Q3 2021 Portfolio in Review
As of Q3 2021, Jeff Yass held 14,193 positions worth $745B, up 4.8% from $712B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Jeff Yass deployed $45.4B of net new capital in Q3 2021, opening 1,741 new positions and adding to 5,205 existing holdings. Its largest new stake was InMode: 613,660 shares worth $48.9M.
By sector, the portfolio is most concentrated in Technology at 1.9% of assets, down from 1.9% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Walt Disney, an estimated $2.17B trimmed.
- Jeff Yass's largest Q3 2021 buy was InMode: 613,660 shares worth $48.9M.
- Jeff Yass added most to Zoom in Q3 2021, an estimated $834M increase.
- Jeff Yass's biggest Q3 2021 reduction was Walt Disney, cutting an estimated $2.17B.
- Jeff Yass fully exited PRA Health Sciences, Inc. in Q3 2021, selling an estimated $103M.
- Jeff Yass's ten largest holdings make up 32% of its $745B portfolio in Q3 2021.
- Jeff Yass opened 1,741 new positions and closed 1,560 in Q3 2021.
- Jeff Yass's portfolio value rose 4.8% quarter-over-quarter to $745B.
Based on Susquehanna International Group's 13F filing for Q3 2021, filed 15 Nov 2021.